FOXO TECHNOLOGIES INC. Financing Cash Flow
FOXO TECHNOLOGIES INC. (FOXO) reported Financing Cash Flow of $139.55 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$300.78K, a 111.15% decline year-over-year.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $440.34K, a 65.77% decline year-over-year.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$298.33K, a 115.87% decline year-over-year.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $973.52K.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) financing activities for fiscal 2025 was $4.66M, a 63.08% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) financing activities for fiscal 2024 was $2.86M, a 144.73% increase from fiscal 2023.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) financing activities for fiscal 2023 was $1.17M, a 95.19% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) financing activities for fiscal 2022 was $24.29M, a 71.74% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 8 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$300.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $139.55K 10-Q · filed 2026-08-14 | -$158.78K derived: sum of 3 quarters · filed 2026-08-14 | $814.74K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | $440.34K 10-Q · filed 2026-05-15 | $142.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.12M derived: sum of 3 quarters · filed 2026-05-15 | $3.81M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | -$298.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $675.18K derived: sum of 2 quarters · filed 2026-04-15 | $3.37M derived: sum of 3 quarters · filed 2026-08-14 | $4.66M 10-K · filed 2026-04-15 | |||||
| 2025-09-30 | $973.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.67M derived: sum of 2 quarters · filed 2026-08-14 | $4.96M 10-Q · filed 2025-11-10 | $6.84M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $3.98M 10-Q · filed 2026-08-14 | $5.86M derived: sum of 3 quarters · filed 2026-08-14 | $5.02M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | $1.29M 10-Q · filed 2026-05-15 | $3.17M derived: sum of 2 quarters · filed 2026-05-15 | $2.32M derived: sum of 3 quarters · filed 2026-05-15 | $3.77M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.03M derived: sum of 2 quarters · filed 2026-04-15 | $2.49M derived: sum of 3 quarters · filed 2026-04-15 | $2.86M 10-K · filed 2026-04-15 | |||||
| 2024-09-30 | -$847.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $606.52K derived: sum of 2 quarters · filed 2025-11-10 | $977.24K 10-Q · filed 2025-11-10 | $977.00K 10-Q · filed 2024-11-19 | $1.45M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $1.45M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | $1.82M 10-Q · filed 2025-08-19 | $1.82M 10-Q · filed 2024-08-19 | $2.30M derived: sum of 3 quarters · filed 2025-08-19 | |||||
| 2024-03-31 | $370.72K 10-Q/A · filed 2025-08-19 | $371.00K 10-Q · filed 2024-06-28 | $846.30K derived: sum of 2 quarters · filed 2025-08-19 | ||||||
| 2023-12-31 | $475.58K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.17M 10-K · filed 2025-04-15 | $1.17M 10-K · filed 2024-06-06 | ||||||
| 2023-09-30 | $692.00K 10-Q · filed 2024-11-19 | ||||||||
| 2022-12-31 | -$271.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$2.80M derived: sum of 2 quarters · filed 2024-06-06 | $1.81M derived: sum of 3 quarters · filed 2024-06-06 | $24.29M 10-K · filed 2024-06-06 | |||||
| 2022-09-30 | -$2.53M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | $2.08M derived: sum of 2 quarters · filed 2024-06-04 | $24.56M 10-Q/A · filed 2024-06-04 | $24.45M derived: sum of 4 quarters · filed 2024-06-04 | |||||
| 2022-06-30 | $4.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $27.09M 10-Q · filed 2023-08-10 | -$89.85M 10-Q · filed 2022-08-12 | $26.98M derived: sum of 3 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | $22.48M 10-Q · filed 2023-05-11 | $200.00K 10-Q · filed 2022-05-16 | $22.37M derived: sum of 2 quarters · filed 2023-05-11 | ||||||
| 2021-12-31 | -$107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $14.14M 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | $14.25M 10-Q · filed 2022-11-21 | ||||||||
| 2020-12-31 | $203.20M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |